CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression

Cellular Oncology

Volumn 35, Issue 4, 2012, Pages 293-300

  Sillars Hardebol, Anke H ^a   Carvalho, Beatriz ^a   Belién, Jeroen A M ^a   De Wit, Meike ^a   Delis Van Diemen, Pien M ^a   Tijssen, Marianne ^a   Van De Wiel, Mark A ^a,b   Pontén, Fredrik ^c   Meijer, Gerrit A ^a   Fijneman, Remond J A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Chromosome 20q gain; Colorectal adenoma to carcinoma progression; CSE1L; DIDO1; Driver genes; RBM39

Indexed keywords

ARTICLE; CANCER GROWTH; CHROMOSOME 20Q; CHROMOSOME SEGREGATION 1 LIKE GENE; COLORECTAL ADENOMA; DIDO1 GENE; GENE AMPLIFICATION; GENE DOSAGE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA BINDING MOTIF PROTEIN 39 GENE;

ADENOMA; CARCINOMA; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 20; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; TISSUE ARRAY ANALYSIS;

EID: 84870044430     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0088-2     Document Type: Article

References (49)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, M.J. Thun, Cancer statistics, 2009. CA Cancer J. Clin. 59, 225 (2009)
2. H. Shinya, W.I. Wolff, Morphology, anatomic distribution and cancer potential of colonic polyps. Ann. Surg. 190, 679 (1979)
3. H. Rajagopalan, C. Lengauer, Aneuploidy and cancer. Nature 432, 338 (2004)
4. A. Esquela-Kerscher, F.J. Slack, Oncomirs -microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259 (2006)
5. A.H. Sillars-Hardebol, B. Carvalho, M. van Engeland, R.J. Fijneman, G.A. Meijer, The adenoma hunt in colorectal cancer screening: defining the target. J. Pathol. 226, 1 (2012)
6. P.M. De Angelis, O.P. Clausen, A. Schjolberg, T. Stokke, Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br. J. Cancer 80, 526 (1999)
7. B. Carvalho, C. Postma, S. Mongera, E. Hopmans, S. Diskin, M.A. van de Wiel, W. van Criekinge, O. Thas, A. Matthai, M.A. Cuesta, J.S. Terhaar Sive Droste, M. Craanen, E. Schrock, B. Ylstra, G.A. Meijer, Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 58, 79 (2009)
8. C. Postma, S. Terwischa, M.A. Hermsen, J.R. van der Sijp, G.A. Meijer, Gain of chromosome 20q is an indicator of poor prognosis in colorectal cancer. Cell. Oncol. 29, 73 (2007)
9. A.H. Sillars-Hardebol, B. Carvalho, M. Tijssen, J.A. Belien, M. de Wit, P.M. Delis-van Diemen, F. Ponten, M.A. van de Wiel, R.J. Fijneman, G.A. Meijer, TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. Gut doi:10.1136/gutjnl-2011-301153 (Epub ahead of print)
10. P. Platzer, M.B. Upender, K. Wilson, J. Willis, J. Lutterbaugh, A. Nosrati, J.K. Willson, D. Mack, T. Ried, S. Markowitz, Silence of chromosomal amplifications in colon cancer. Cancer Res. 62, 1134 (2002)
11. M. de Wit, C.R. Jimenez, B. Carvalho, J.A. Belien, P.M. Delis-van Diemen, S. Mongera, S.R. Piersma, M. Vikas, S. Navani, F. Ponten, G.A. Meijer, R.J. Fijneman, Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression. Gut 61, 855 (2012)
12. M. Uhlen, E. Bjorling, C. Agaton, C.A. Szigyarto, B. Amini, E. Andersen, A.C. Andersson, P. Angelidou, A. Asplund, C. Asplund, L. Berglund, K. Bergstrom, H. Brumer, D. Cerjan, M. Ekstrom, A. Elobeid, C. Eriksson, L. Fagerberg, R. Falk, J. Fall, M. Forsberg, M.G. Bjorklund, K. Gumbel, A. Halimi, I. Hallin, C. Hamsten, M. Hansson, M. Hedhammar, G. Hercules, C. Kampf, K. Larsson, M. Lindskog, W. Lodewyckx, J. Lund, J. Lundeberg, K. Magnusson, E. Malm, P. Nilsson, J. Odling, P. Oksvold, I. Olsson, E. Oster, J. Ottosson, L. Paavilainen, A. Persson, R. Rimini, J. Rockberg, M. Runeson, A. Sivertsson, A. Skollermo, J. Steen, M. Stenvall, F. Sterky, S. Stromberg, M. Sundberg, H. Tegel, S. Tourle, E. Wahlund, A. Walden, J. Wan, H. Wernerus, J. Westberg, K. Wester, U. Wrethagen, L.L. Xu, S. Hober, F. Ponten, A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell Proteomics. 4, 1920 (2005)
13. M. Uhlen, P. Oksvold, L. Fagerberg, E. Lundberg, K. Jonasson, M. Forsberg, M. Zwahlen, C. Kampf, K. Wester, S. Hober, H. Wernerus, L. Bjorling, F. Ponten, Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248 (2010)
14. U. Brinkmann, E. Brinkmann, M. Gallo, I. Pastan, Cloning and characterization of a cellular apoptosis susceptibility gene, the human homologue to the yeast chromosome segregation gene CSE1. Proc. Natl. Acad. Sci. U. S. A. 92, 10427 (1995)
15. U. Brinkmann, E. Brinkmann, M. Gallo, U. Scherf, I. Pastan, Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. Biochemistry 35, 6891 (1996)
16. U. Brinkmann, CAS, the human homologue of the yeast chromosome- segregation gene CSE1, in proliferation, apoptosis, and cancer. Am. J. Hum. Genet. 62, 509 (1998)
17. A. Wellmann, L. Krenacs, T. Fest, U. Scherf, I. Pastan, M. Raffeld, U. Brinkmann, Localization of the cell proliferation and apoptosisassociated CAS protein in lymphoid neoplasms. Am. J. Pathol. 150, 25 (1997)
18. Z. Xiao, J.T. McGrew, A.J. Schroeder, M. Fitzgerald-Hayes, CSE1 and CSE2, two new genes required for accurate mitotic chromosome segregation in Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 4691 (1993)
19. C.F. Liao, S.F. Luo, L.T. Li, C.Y. Lin, Y.C. Chen, M.C. Jiang, CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J. Exp. Clin. Cancer Res. 27, 15 (2008)
20. C.J. Tai, S.C. Shen, W.R. Lee, C.F. Liao, W.P. Deng, H.Y. Chiou, C.I. Hsieh, J.N. Tung, C.S. Chen, J.F. Chiou, L.T. Li, C.Y. Lin, C.H. Hsu, M.C. Jiang, Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp. Cell Res. 316, 2969 (2010)
21. U. Brinkmann, M. Gallo, M.H. Polymeropoulos, I. Pastan, The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Res. 6, 187 (1996)
22. A.B. Hui, K.W. Lo, P.M. Teo, K.F. To, D.P. Huang, Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. Int. J. Oncol. 20, 467 (2002)
23. C.Y. Tong, A.B. Hui, X.L. Yin, J.C. Pang, X.L. Zhu, W.S. Poon, H.K. Ng, Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J. Neurosurg. 100, 187 (2004)
24. H. Brustmann, Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study. Gynecol. Oncol. 92, 268 (2004)
25. K. Shiraki, K. Fujikawa, K. Sugimoto, T. Ito, T. Yamanaka, M. Suzuki, K. Yoneda, K. Sugimoto, K. Takase, T. Nakano, Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma. Int. J. Mol. Med. 18, 77 (2006)
26. I.M. Seiden-Long, K.R. Brown,W. Shih, D.A.Wigle, N. Radulovich, I. Jurisica, M.S. Tsao, Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. Oncogene 25, 91 (2006)
27. A. Wellmann, P. Flemming, P. Behrens, K. Wuppermann, H. Lang, K. Oldhafer, I. Pastan, U. Brinkmann, High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: Correlation with tumor progression. Int. J. Mol. Med. 7, 489 (2001)
28. P. Behrens, U. Brinkmann, F. Fogt, N. Wernert, A. Wellmann, Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development. Anticancer. Res. 21, 2413 (2001)
29. G. Peiro, J. Diebold, G.B. Baretton, R. Kimmig, U. Lohrs, Cellular apoptosis susceptibility gene expression in endometrial carcinoma: Correlation with Bcl-2, Bax, and caspase-3 expression and outcome. Int. J. Gynecol. Pathol. 20, 359 (2001)
30. T.R. Kau, J.C. Way, P.A. Silver, Nuclear transport and cancer: From mechanism to intervention. Nat. Rev. Cancer 4, 106 (2004)
31. U. Kutay, F.R. Bischoff, S. Kostka, R. Kraft, D. Gorlich, Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell 90, 1061 (1997)
32. K.S. Ullman, M.A. Powers, D.J. Forbes, Nuclear export receptors: From importin to exportin. Cell 90, 967 (1997)
33. K.M. Ryan, A.C. Phillips, K.H. Vousden, Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332 (2001)
34. W.C. Uen, C.J. Tai, S.C. Shen, W.R. Lee, T.Y. Tsao, W.P. Deng, H.Y. Chiou, C.H. Hsu, C.I. Hsieh, C.F. Liao, M.C. Jiang, Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium. J. Mol. Histol. 41, 259 (2010)
35. C.S. Stella Tsai, H.C. Chen, J.N. Tung, S.S. Tsou, T.Y. Tsao, C.F. Liao, Y.C. Chen, C.Y. Yeh, K.T. Yeh, M.C. Jiang, Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer. Am. J. Pathol. 176, 1619 (2010)
36. T.Y. Tsao, C.S. Tsai, J.N. Tung, S.L. Chen, C.H. Yue, C.F. Liao, C.C. Wang, M.C. Jiang, Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol. Cell. Biochem. 327, 163 (2009)
37. R.J. Fijneman, M. de Wit, M. Pourghiasian, S.R. Piersma, T.V. Pham, M.O. Warmoes, M. Lavaei, C. Piso, F. Smit, P.M. Delis-van Diemen, S.T. van Turenhout, J.S.Terhaar sive Droste, C.J. Mulder, M.A. Blankenstein, E.C. Robanus-Maandag, R. Smits, R. Fodde, V.W. van Hinsbergh, G.A. Meijer, C.R. Jimenez, Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer. Clin. Cancer Res. 18, 2613 (2012)
38. U. Scherf, I. Pastan, M.C. Willingham, U. Brinkmann, The human CAS protein which is homologous to the CSE1 yeast chromosome segregation gene product is associated with microtubules and mitotic spindle. Proc. Natl. Acad. Sci. U. S. A. 93, 2670 (1996)
39. A.H. Sillars-Hardebol, B. Carvalho, M. de Wit, C. Postma, P.M. Delis-van Diemen, S. Mongera, B. Ylstra, M.A. van de Wiel, G.A. Meijer, R.J. Fijneman, Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression. Tumour. Biol. 31, 89 (2010)
40. D. Garcia-Domingo, D. Ramirez, G. Gonzalez de Buitrago, A. Martinez, Death inducer-obliterator 1 triggers apoptosis after nuclear translocation and caspase upregulation. Mol. Cell. Biol. 23, 3216 (2003)
41. V. Trachana,K.H. vanWely,A.A. Guerrero, A. Futterer,A.Martinez, Dido disruption leads to centrosome amplification andmitotic checkpoint defects compromising chromosome stability. Proc. Natl. Acad. Sci. U. S. A. 104, 2691 (2007)
42. A.M. Rojas, L. Sanchez-Pulido, A. Futterer, K.H. van Wely, A. Martinez, A. Valencia, Death inducer obliterator protein 1 in the context of DNA regulation. Sequence analyses of distant homologues point to a novel functional role. FEBS J. 272, 3505 (2005)
43. D.J. Jung, S.Y. Na, D.S. Na, J.W. Lee, Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors. J. Biol. Chem. 277, 1229 (2002)
44. D.H. Dowhan, E.P. Hong, D. Auboeuf, A.P. Dennis, M.M.Wilson, S.M. Berget, B.W. O'Malley, Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERalpha and CAPERbeta. Mol. Cell 17, 429 (2005)
45. A. Srebrow, A.R. Kornblihtt, The connection between splicing and cancer. J. Cell Sci. 119, 2635 (2006)
46. J.P. Venables, Unbalanced alternative splicing and its significance in cancer. Bioessays 28, 378 (2006)
47. M.J. Moore, Q. Wang, C.J. Kennedy, P.A. Silver, An alternative splicing network links cell-cycle control to apoptosis. Cell 142, 625 (2010)
48. C.S. Bangur, A. Switzer, L. Fan, M.J. Marton, M.R. Meyer, T. Wang, Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis. Oncogene 21, 3814 (2002)
49. I. Mercier, M.C. Casimiro, J. Zhou, C. Wang, C. Plymire, K.G. Bryant, K.M. Daumer, F. Sotgia, G. Bonuccelli, A.K. Witkiewicz, J. Lin, T.H. Tran, J. Milliman, P.G. Frank, J.F. Jasmin, H. Rui, R.G. Pestell, M.P. Lisanti, Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. Am. J. Pathol. 174, 1172 (2009)